Validating a New Machine-Learned Accelerometer Algorithm Using Doubly Labeled Water
Part of paid clinical trials in Milwaukee, Wisconsin.
- Sponsor
- University of Wisconsin, Milwaukee
- Study ID
- NCT05736302
- Status
- Recruiting
Conditions
- Energy Metabolism
- Movement Disorders
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Doubly-Labeled Water — OTHERAll eligible participants will receive a dose of doubly-labeled water.
Study Details
The purpose of this study is to validate previously developed physical function-clustered specific machine-learned accelerometer algorithms to estimate total daily energy expenditure (TDEE) in individuals with general movement and functional limitations.
Key Dates
- Start date
- Mar 14, 2023
- Status verified
- Apr 2026
- Primary completion
- Aug 28, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 125 participants (estimated)
Arms
- Arm: Individuals without movement limitationsIndividuals who are not classified as impaired or functionally limited per results of physical function testing.
- Arm: Individuals with impaired movementIndividuals who are classified as impaired, but not functionally limited per results of physical function testing.
- Arm: Individuals with impaired movement who are functionally impairedIndividuals who are classified as impaired and functionally limited per results of physical function testing.
Primary Outcome Measure
Accuracy of accelerometer derived estimations of total daily energy expenditure (TDEE, kcals/day). [ Time Frame: 8-10 days monitoring ]
Central Contacts
- Katharine O'Connell Valuch414-229-4115
- Scott Strath, PhD
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Wisconsin-Milwaukee | Milwaukee | Wisconsin | 53211 | Katharine O'Connell Valuch Scott Strath |
Find similar trials in Milwaukee, WI
By research site
Related Studies
- Botulinum Toxin for the Treatment of Involuntary Movement DisordersRecruiting · National Institute of Neurological Disorders and Stroke (NINDS) · Bethesda, Maryland
- Neurophysiological, Behavioral, and Cognitive Networks in Movement DisordersRecruiting · University of Alabama at Birmingham · Birmingham, Alabama
- Abbott DBS Post-Market Study of Outcomes for Indications Over TimeRecruiting · Abbott Medical Devices · Tucson, Arizona
- SLC13A5 Deficiency Natural History Study - Remote OnlyEnrolling By Invitation · TESS Research Foundation · Palo Alto, California